Cita APA (7a ed.)
Mekahli, D., Guay-Woodford, L. M., Cadnapaphornchai, M. A., Goldstein, S. L., Dandurand, A., Jiang, H., . . . Debuque, L. (2024). Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: A randomized trial of tolvaptan. Pediatric Nephrology, 39(5), 1481-1491.
Cita Chicago Style (17a ed.)
Mekahli, Djalila, Lisa M. Guay-Woodford, Melissa A. Cadnapaphornchai, Stuart L. Goldstein, Ann Dandurand, Huan Jiang, Pravin Jadhav, y Laurie Debuque. "Estimating Risk of Rapid Disease Progression in Pediatric Patients with Autosomal Dominant Polycystic Kidney Disease: A Randomized Trial of Tolvaptan." Pediatric Nephrology 39, no. 5 (2024): 1481-1491.
Cita MLA (9a ed.)
Mekahli, Djalila, et al. "Estimating Risk of Rapid Disease Progression in Pediatric Patients with Autosomal Dominant Polycystic Kidney Disease: A Randomized Trial of Tolvaptan." Pediatric Nephrology, vol. 39, no. 5, 2024, pp. 1481-1491.
Precaución: Estas citas no son 100% exactas.